Prostatis Group’s Marathon Petroleum MPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Buy
1,377
+69
+5% +$16.9K 0.08% 130
2026
Q1
$319K Sell
1,308
-63
-5% -$12.7K 0.08% 138
2025
Q4
$223K Buy
+1,371
New +$256K 0.05% 157
2025
Q1
Sell
-1,721
Closed -$240K 157
2024
Q4
$240K Sell
1,721
-29
-2% -$4.43K 0.07% 140
2024
Q3
$285K Buy
+1,750
New +$296K 0.09% 114
2024
Q2
Sell
-1,702
Closed -$343K 152
2024
Q1
$343K Buy
+1,702
New +$291K 0.13% 110

Other funds holding MPC

Prostatis Group's MPC Position: Q2 2026 in Review

Prostatis Group increased its Marathon Petroleum (MPC) stake by 5.3% in Q2 2026, buying an estimated $16.9K and bringing the position to 1,377 shares worth $352K. The position accounts for 0.08% of the portfolio, ranked #130.

Prostatis Group first reported a position in MPC in Q1 2024 and has held it in 6 quarters since. 1,942 funds tracked by Wall St. Rank hold MPC as of Q2 2026.

  • Prostatis Group held 1,377 shares of Marathon Petroleum worth $352K as of Q2 2026.
  • Prostatis Group bought 69 Marathon Petroleum shares in Q2 2026, an estimated $16.9K.
  • Marathon Petroleum made up 0.08% of Prostatis Group's portfolio in Q2 2026, its #130 holding.
  • Prostatis Group first reported a position in Marathon Petroleum in Q1 2024 and has held it in 6 quarters since.
  • 1,942 funds tracked by Wall St. Rank held Marathon Petroleum as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.